Among 12 patients in this study, 8 showed partial response and 4 had stable disease without any other concurrent treatment for recurrent GBM, such as surgery, radiation, or chemotherapy and with merely a single intratumoral stereotactic injection of allogeneic ADSCs carrying HSV-TK gene followed by prodrug administration. The gene discussed is TKT; the disease is glioblastoma.